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Abstract
A leucine zipper motif is conserved in the cytoplasmic domain of glycoprotein gp41 (gp41c) of all 
HIV-1 subtypes, but is not present in HIV-2 or SIV. The second leucine residue of the leucine 
zipper was mutated (L95R) to determine the role of this motif in HIV-1 replication and 
pathogenesis. The L95R mutant replicated to wild-type levels in activated peripheral blood 
mononuclear cells and CEMx174 cells. However, L95R replication was impaired in SupT1 cells 
and in the SCID-hu Thy/Liv mouse. Although the infectivity of wild-type virions and that of L95R 
mutant virions were equally sensitive to heat treatment, we found that L95R produced more 
defective virions, due to reduced surface expression and virion incorporation of the env 
glycoprotein. These results suggest that the L95 residue in the leucine zipper of gp41c of HIV-1 
plays an important role in the env expression and virion incorporation that is required for viral 
replication and pathogenesis in the SCID-hu Thy/Liv mouse. The leucine zipper motif in gp41c 
may provide a novel anti-HIV-1 target.
INTRODUCTION
Like other lentivirus transmembrane (TM) glycoproteins, the TM glycoprotein (gp41) of 
HIV-1 has a long cytoplasmic domain of 150 amino acids (residues 704–854, gp41c). 
Deletions of gp41c impair HIV-1 replication and infectivity (Dubay et al., 1992; Gabuzda et 
al., 1992; Lee et al., 1989; Yu et al., 1993). The gp41c domains appear to be required in a 
cell type-dependent (Akari et al., 2000; Gabuzda et al., 1992; Murakami and Freed, 2000) 
and species-dependent fashion (Johnston et al., 1993; Kodama et al., 1989), suggesting that 
a host cell factor is involved. For instance, simian immunodeficiency virus (SIV) mutants 
with truncation mutations in gp41c arise from selection in human cells. However, infection 
of rhesus macaque peripheral blood lymphocytes in vitro or in vivo with the SIV mutant 
results in rapid reversion to full-length gp41 (Kodama et al., 1989).
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The C-terminal domain of gp41 encodes a Tyr-based motif that mediates internalization of 
HIV-1 glycoproteins via interaction with the AP2 clathrin adaptor protein (Boge et al., 
1998) and two lentivirus lytic peptides (LLPs), which are capable of binding and disturbing 
lipid bilayers (Miller et al., 1991). The ability of LLP-1 (residues 768–788) and LLP-2 
(residues 826–854) to interact with lipid bilayers suggests membrane-related functions. 
LLP-1 also interacts with calmodulin (Miller et al., 1993; Srinivas et al., 1993) and LLP-2 
inhibits Ca2+-dependent T-cell activation (Beary et al., 1998), implicating these amphipathic 
helices in protein–protein interactions and signal transduction. A leucine zipper motif 
(residues 789–815) in HIV-1 gp41c has also been shown to interact with lipid bilayers 
(Kliger and Shai, 1997). Mutational analysis has shown that this amphipathic helix region of 
gp41c is involved in its interaction with p115-RhoGEF, a specific guanine nucleotide 
exchange factor and activator of the RhoA GTPase (Zhang et al., 1999).
We examined the role of this leucine zipper in HIV-1 replication and pathogenesis by 
mutating the second leucine residue of this motif (L95, amino acid 95 of gp41c or residue 
798 of gp160) to an arginine residue. The L95R mutant replicated to wild-type (NL4-3) 
levels in peripheral blood mononuclear cells (PBMC) and CEMx174 cells. However, L95R 
replication was impaired in SupT1 cells and in the SCID-hu Thy/Liv mouse. The L95R 
mutant env fused efficiently to both SupT1 and CEMx174 cells and L95R mutant virions 
showed wild-type sensitivity to heat inactivation. We showed that the L95R mutation 
impaired HIV-1 replication by reducing surface expression and virion incorporation of the 
env glycoprotein. The findings demonstrate that the L95 residue in the leucine zipper motif 
of gp41c plays an important role in the surface expression and incorporation of env proteins 
into infectious HIV-1 virions, which is required for efficient HIV-1 replication and 
pathogenesis in vivo.
RESULTS
Cell type-dependent phenotypes of the L95R mutant
A putative leucine zipper (LZ) motif (LX6LX6LX6L) within the cytoplasmic domain of 
gp41 (gp41c) of HIV-1 is conserved in all HIV-1 subtypes in the Los Alamos HIV 
databases. This LZ motif, however, is not present in the HIV-2 or SIV transmembrane 
proteins (data not shown). To examine the function of the leuzine zipper motif within the 
cytoplasmic domain of HIV-1 gp41, a point mutation (L95R) was introduced at amino acid 
position 95 of gp41c (Fig. 1a). L95 is the second leucine within the putative leucine zipper 
motif. The L95R mutation did not affect the amino acid coded in the overlapping rev open 
reading frame.
To compare the replication activity of the mutant L95R virus with that of wild-type NL4-3 
virus, human T-lymphoid cell lines and phytohemagglutinin (PHA)-stimulated PBMC were 
infected and virus replication was monitored by measuring reverse transcriptase (RT) 
activity in the culture supernatants. L95R replication was impaired in SupT1 (Fig. 1b), 
Jurkat, and H9 cell lines (Zhang et al., 1999). However, L95R showed no observable 
replication defect in PHA-activated PBMC and CEMx174 cells (Fig. 1b). L95R virus 
reached similar peak RT activity at a rate equivalent to that of NL4-3. The results suggest 
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that the leucine zipper of gp41c plays a role in cell type-dependent HIV-1 replication in 
vitro.
Impaired HIV-1 replication and pathogenicity of L95R in the SCID-hu Thy/Liv mouse
To examine the possible replication defect of the L95R mutant in vivo, SCID-hu Thy/Liv 
mice were infected with equivalent infectious units of NL4-3 or L95R. NL4-3 virus 
replication was detected at 2 weeks postinfection (wpi) and peaked at 4 wpi, with an average 
p24 level of 1037 pg per 106 thymocytes at 2 wpi and 3085 pg per 106 thymocytes at 4 wpi 
(Fig. 2a). In contrast, L95R virus replication was significantly reduced at 2 and 4 wpi, with 
an average p24 level of 80 and 660 pg per 106 thymocytes, respectively (Fig. 2a). In 
accordance with the p24 data, L95R failed to induce MHC I expression at 2 wpi and induced 
lower levels at 4 wpi (data not shown), which is accompanied by HIV-1 replication in the 
SCID-hu Thy/Liv mouse (Kovalev et al., 1999).
NL4-3 virus replication is accompanied by preferential depletion of CD4+CD8+ and 
CD4+CD8− thymocytes (Su et al., 1995). In parallel to impaired virus replication, 
pathogenesis of L95R was impaired (Figs. 2b and 2c). At 4 wpi, the percentage of total 
CD4+ thymocytes in NL4-3-infected Thy/Liv organs decreased significantly (P < 0.001) 
compared with that of mock-infected Thy/Liv organs (set at 100%). On the other hand, 
L95R induced no significant thymocyte depletion by 4 wpi (Figs. 2b and 2c). For example, 
the total CD4+ thymocytes of NL4-3-infected Thy/Liv organs decreased to about 40% of 
mockinfected Thy/Liv organs at 4 wpi. In contrast, the L95R-infecteed Thy/Liv organs 
showed no significant decrease in CD4+ thymocyte populations, compared with mock-
infecteed Thy/Liv organs. L95R was also impaired in other measurements of pathogenesis, 
including a decrease in the total percentage of live cells (based on light scatter profiles) and 
inversion of the CD4/CD8 ratio (Fig. 2c, and data not shown). Therefore, the L95 residue in 
the LZ motif of gp41c was required for efficient HIV-1 replication and pathogenesis in vivo.
The L95R mutant env protein did not affect the early stage of the virus life cycle and L95R 
virions showed similar sensitivity to heat inactivation
A single-cycle infectivity assay was performed using pseudotyped viruses generated from an 
env expression vector and an env-deficient HIV-1 provirus containing a luciferase reporter 
gene, NL4-luc-R−E− (Connor et al., 1995). This infectivity assay assesses the ability of the 
env protein to mediate binding, fusion, and uncoating of the pseudotyped virion in the 
context of virus-to-cell transmission. SupT1 or CEMx174 cells were infected with 
equivalent infectious units of the pseudotyped viruses produced from 293T cells and 
luciferase expression was assayed at 2 days postinfection (dpi). The L95R-env pseudotyped 
virus was able to produce levels of luciferase equivalent to that of NL4-3 in SupT1 cells 
(Fig. 3, left). Similar results were obtained in CEMx174 cells (Fig. 3, right). Virus stocks 
derived from either defective provirus (NL4-luc-R−E−) or env (pcDNA3-env) alone were 
not infectious (data not shown). These data suggest that the L95R mutant env functioned 
normally in the pseudotyped viruses when expressed from a CMV promoter.
We tested the stability of L95R virions to heat inactivation by incubating NL4-3 and L95R 
virions at various temperatures (Fig. 4). Both NL4-3 and L95R virions were similarly heat-
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inactivated at 41 to 49°C and completely inactivated at 53 and 57°C. These results suggest 
that L95R virions, once assembled and released, were similarly sensitive to heat inactivation 
in comparison to wildtype virions.
The L95R mutation reduced surface expression of the gp120 env glycoprotein
To determine the expression and subcellular localization of L95R mutant glycoproteins, 
surface expression of gp120 and intracellular expression of gp120 and gp41 were studied by 
indirect immunofluorescence (Fig. 5a). 293T cells transfected with NL4-3 or L95R proviral 
DNA showed no discernible differences in subcellular localization of gp120 or gp41.
Cell surface expression of gp120 was measured by FACS analysis of T cells infected with 
VSV G-pseudotyped NL4-3 and L95R viruses (Fig. 5b). Both CEMx174 and SupT1 cells 
infected with L95R showed decreased levels of cell surface expression of gp120 compared 
to NL4-3-infected cells. A twofold reduction of mean fluorescence intensity (MFI) was 
reproducibly observed in both CEMx174 and SupT1 cells. The data suggest that the L95R 
mutation reduced the cell surface expression of env glycoproteins.
L95R produced more defective particles
T-cell lines and 293T cells were transfected with proviral DNA and culture supernatants 
were analyzed by RT (total virions) and infectious unit (IU, infectious virions) assays. 
Transfection of L95R proviral DNA into 293T cells yielded comparable reverse RT activity 
(total virions) in culture supernatants to that of wild-type NL4-3 (data not shown). However, 
L95R viral stocks contained 32% less IU than NL4-3 viral stocks (P < 0.01), indicating that 
L95R produced more defective viral particles than NL4-3 (Fig. 6a). Transfection of L95R 
proviral DNA in SupT1 and CEMx174 cells also yielded RT activity equivalent to 
transfection of NL4-3 provirus, suggesting that the L95R mutant did not affect the 
expression, assembly, and release of total viral particles (data not shown). However, L95R 
produced significantly less infectious units in SupT1 (70% reduction) or CEMx174 (50% 
reduction) cells, as indicated by the ratio of IUs to RT units (IU/RT, Fig. 6a). These data 
indicate that the L95R mutation affected the assembly or stability of infectious virions.
The L95R mutation decreased env glycoprotein incorporation into virions
To examine viral protein expression, virion assembly, and virion release, cell lysates or 
pelleted virions from 293T cells transfected with proviral DNA were analyzed by Western 
blot using antibodies specific for gp41, gp120, or p24 (Fig. 6b and Table 1). Comparable 
levels of cell-associated gp41 and gp120 (relative to levels of p24/p25) were synthesized 
upon transfection of NL4-3 and L95R proviruses, indicating that the L95R mutation did not 
significantly affect the synthesis and proteolytic cleavage of the env precursor. Virions in 
culture supernatants were pelleted by centrifugation in a 20% sucrose cushion and also 
analyzed by Western blot. Relative to p24 levels, L95R virions contained approximately 
two- to fivefold less gp41 and gp120 than NL4-3 virions, suggesting a possible defect in 
virion incorporation of gp120/gp41 (Table 1).
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The L95R mutant was constructed to investigate the role of a leucine zipper motif in gp41c 
in HIV-1 replication and pathogenesis. We report that the L95R mutation in the leucine 
zipper motif in gp41c impaired HIV-1 replication and pathogenesis in vivo by reducing the 
surface expression and virion incorporation of env glycoproteins.
L95R replicated to wild-type levels in PHA-stimulated PBMC and CEMx174 cells, but was 
impaired in SupT1, Jurkat, and H9 cell lines (Fig. 1 and Zhang et al., 1999). In two recent 
reports, gp41c deletion or truncation mutants replicate in a cell type-dependent manner in 
vitro probably due to defective env incorporation in virions (Akari et al., 2000; Murakami 
and Freed, 2000). Using a truncation mutant lacking all but six amino acids in gp41c, 
Murakami and Freed (2000) have recently reported a similar replication-defective phenotype 
as L95R in Jurkat and SupT1 cells. This mutant replicates to wild-type levels in MT-4 cells. 
In contrast to L95R, however, this and other gp41c truncation mutants are also unable to 
replicate in PBMC (Dubay et al., 1992; Murakami and Freed, 2000; Yu et al., 1993). The 
discrepancy between gp41c truncation mutants and L95R may be because the truncation 
mutants also lack potential functional domains in addition to the leucine zipper in gp41c. It 
is possible that replication in PBMC, unlike that in Jurkat and SupT1 cells, requires 
functional motifs in gp41c other than the leucine zipper. This difference between the L95R 
mutant and the gp41c truncation mutants also suggests that the L95R mutation probably 
disrupted a specific functional domain (LZ) of gp41c, but not the entire gp41c structure.
L95R replication was impaired in the SCID-hu Thy/Liv model (Fig. 2) or in the human fetal 
thymus organ culture (HF-TOC) model (S. Kao and L. Su, unpublished results). The in vivo 
models entail virus replication in a repertoire of cell types. The reduced pathogenic effects 
of L95R were likely a consequence of reduced replication since the L95R replication level 
was generally below the threshold of thymocyte depletion mediated by NL4-3 (Su et al., 
1995). In the SCID-hu Thy/Liv mice with higher levels of L95R replication, reduction in 
cytopathic effects in L95R-infected SCID-hu Thy/Liv mice was proportional to reduction in 
HIV-1 replication (Fig. 2; and data not shown).
The block in L95R virus replication may occur after HIV-1 gene expression since L95R-env 
pseudotyped virions were able to undergo a single round of replication at wild-type levels in 
both SupT1 and CEMx174 cells (Fig. 3). It is possible the L95R replication defect in SupT1 
cells may manifest itself only after multiple rounds of replication. Alternatively, 
overexpression of L95R mutant env from the strong CMV promoter in the pcDNA3 vector 
in cotransfected 293T cells may have compensated for the putative defect. Our preliminary 
results showed that the IU/RT ratio of L95R-env pseudotyped viruses was the same as that 
for NL4-env pseudotyped viruses (data not shown). This suggests that one defect of L95R 
replication may be in the level of env expression.
The L95R mutation appeared to interfere with envelope glycoprotein surface expression and 
incorporation into virions (Figs. 5 and 6). Normal levels of surface env protein are expressed 
by some gp41c truncation mutants (Dubay et al., 1992; Murakami and Freed, 2000; Yu et 
al., 1993). However, previous reports have also shown that truncation of gp41c affects 
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virion incorporation of env glycoprotein (Akari et al., 2000; Dubay et al., 1992; Murakami 
and Freed, 2000). It has been suggested that the cell type-dependent virion incorporation of 
env glycoproteins of gp41c mutants may result in the cell type-dependent replication 
phenotype (Akari et al., 2000; Murakami and Freed, 2000). However, other studies have 
shown that gp41c truncation mutations do not affect env glycoprotein incorporation into 
virions (Gabuzda et al., 1992; Johnston et al., 1993; Mammano et al., 1995; Salzwedel et 
al., 1993; Wilk et al., 1992). These discrepancies may be mollified by the specific mutations 
studied and/or the cell types used to study the effects of the various mutations on virus 
replication.
In this report, we failed to detect any dramatic differences in permissive (CEMx174) and 
restrictive (SupT1) cell lines either transfected or infected with L95R and NL4-3. Thus, 
similar reduction in surface expression of gp120 (Fig. 5b) and production of defective L95R 
virions (Fig. 6a) were detected in CEMx174 and SupT1 cells. The seemingly less dramatic 
reduction in IU/RT ratios of L95R in CEMx174 cells (50% of NL4-3) than in SupT1 cells 
(30% of NL4-3) may contribute to the cell type-dependent replication. The CEMx174 cell 
line is a fusion product of the human B-cell line 721.174 and human T-cell line CEM (Salter 
et al., 1985). These cells may contain a host factor (from B cells?) that facilitates virus 
replication despite decreased surface expression and virion incorporation of env 
glycoproteins. Transfection of T cells with proviral DNA or infection by VSV-G 
pseudotyped HIV-1 assesses only a single round of replication. Since L95R replicated to 
wild-type levels in CEMx174 cells (Fig. 1) over multiple rounds of replication, the defect of 
L95R mutant in CEMx174 may potentially be compensated for during cell-to-cell 
transmissions. Interestingly, the L95R mutant replication in SupT1 cells was detectable at 
21–24 days postinfection (Fig. 1b). The recovered viruses were not due to reversion of L95R 
because they showed replication kinetics similar to that of the parental L95R in SupT1 cells 
(S. Kao and L. Su, unpublished results), suggesting a delayed replication kinetics of L95R in 
SupT1 cells. In L95R-infected SCID-hu Thy/Liv organs, decreased env surface expression 
and virion incorporation were likely responsible for the impaired replication and 
pathogenesis (Fig. 2).
The cell type-dependence phenotype of L95R strongly suggests the involvement of a host 
factor(s) in mediating the effects of gp41c. It is of interest that the permissive PBMC and 
CEMx174 cells for L95R replication are also permissive for wild-type SIV replication, 
whose TM gp41 proteins lack the LZ motif (L. Su, unpublished results). Both the SIV gp41c 
and the HIV-1 L95R gp41c failed to interact with the host protein p115 RhoGEF that 
interacts with wild-type HIV-1 gp41c (Zhang et al., 1999). Our data showed that T-cell lines 
(SupT1, Jurkat, and H9) and SCID-hu Thy/Liv organs expressed high levels of p115, 
whereas no significant p115 was detected in PHA-activated PBMC (unpublished results). 
The interaction of gp41c with p115 may be important to overcome the inhibitory effect of 
p115 and RhoA (Wang et al., 2000).
Other host cell factors may also contribute to the cell type-dependent replication phenotypes 
of gp41c mutants. For example, a specific tyrosine-based sorting motif (YXXO, where X is 
any amino acid and O is an amino acid with a bulky hydrophobic side chain) is the principal 
motif responsible for the basolateral targeting of env glycoprotein and polarized budding of 
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viral particles (Lodge et al., 1997). The interaction of this motif in gp41c with the AP-2 
clathrin complex has been reported to mediate rapid glycoprotein internalization (Boge et 
al., 1998). The gp41c domain has also been shown to interact with α-catenin (Kim et al., 
1999), but the biological significance of the interaction is not clear. Further studies need to 
be conducted to determine the relationship between the host factor(s) and L95R mutant 
replication. Understanding the role of the LZ motif in gp41c will help to elucidate the 
structure and function of gp41c and define a novel target for anti-HIV therapy.
MATERIALS AND METHODS
Cells
293T and U-373-MAGI-CXCR4 (Vodicka et al., 1997) cells were maintained in Dulbecco’s 
modified Eagle’s medium supplemented with 10% heat-inactivated etal bovine serum 
(FBS). PBMC and T-cell lines were cultured in RPMI 1640 containing 10% heat-inactivated 
FBS. The CEMx174 cell line is a fusion product of the human B-cell line 721.174 and 
human T-cell line CEM (Salter et al., 1985). The SupT1 cell line is a non-Hodgkin’s T-cell 
lymphoma (Smith et al., 1984).
Construction of the L95R mutant
To construct an infectious NL4-3 proviral clone containing the L95R mutation in gp41, 
primers with the introduced mutation (nt 8590–8637) were used to perform site-directed 
mutagenesis using the QuikChange Site-Directed Mutagenesis protocol (Stratagene). The 
mutated HIV-1 fragment was sequenced and cloned into the proviral DNA clone pNL4-3 
(Adachi et al., 1986).
DNA transfection
293T cells were transfected with NL4-3 or L95R proviral DNA using Effectene (Qiagen). 
To transfect various T-cell lines, cells were electroporated using a Gene Pulser (Bio-Rad) at 
0.2 kV and 960 µF. Culture supernatant was harvested 48 h posttransfection (hpt) and total 
virions were measured by RT activity (Buckheit and Swanstrom, 1991). The infectious 
virion was titered on U-373-MAGI-CXCR4 indicator cells.
Viral replication in vitro
Relative virus infectivity was assayed in PHA-activated PBMC, CEMx174, and SupT1 
cells. A total of 5 × 105 cells were infected with viral supernatants containing 105 RT units. 
Culture supernatants were monitored for RT activity every 3 days.
HIV-1 replication and pathogenesis in SCID-hu Thy/Liv mice
Infection of SCID-hu Thy/Liv mice was performed as previously described (Kovalev et al., 
1999; Su et al., 1995).
Pseudotyped virus production and infection
pcENV-NL4 is a pcDNA3-based vector containing the EcoRI–XhoI fragment of the NL4-3 
env gene (H. Zhang and L. Su, UNC-CH). The EcoRI–XhoI fragment of L95R was cloned 
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into pcDNA3 to produce the pcENV-L95R plasmid construct. 293T cells were cotransfected 
with 0.4 µg each of the env-deficient pNL43-Luc-R−E− reporter genome (Connor et al., 
1995) and pcENV-NL4 or pcENV-L95R env expression vector using Effectene Transfection 
Reagent (Qiagen) as described above. Supernatants containing the pseudotyped viruses were 
collected 48 hpt and analyzed by luciferase, RT, and MAGI assays.
CEMx174 and SupT1 cells were infected for 2–4 h with supernatants containing equivalent 
infectious units (MAGI IU, determined as above) of pseudotyped viruses in the presence of 
8 µg/ml polybrene. Cells were then washed three times with PBS to remove residual virus 
particles. Two days postinfection, cells were washed once with PBS and lysed for luciferase 
activity.
Heat-stability analysis of HIV-1 stocks
Equal numbers of NL4-3 or L95R infectious units determined on MAGI cells were 
incubated at the indicated temperatures for 10 min and the remaining IUs were determined 
on U-373-MAGI-CXCR4 indicator cells as above. Triplicate samples were included in each 
experiment.
Western blot analysis
Transfected 293T cells were lysed 48 hpt in 0.5% NP-40 lysis buffer. To detect viral 
proteins in virions, supernatants containing viruses were centrifuged for 2 h at 4°C in a 
standard 20% sucrose cushion (Akari et al., 2000). Viral pellets were lysed in 1% Triton 
X-100 and analyzed by standard Western blot with anti-gp41 (Abacioglu et al., 1994), anti-
gp120 (Chesebro and Wehrly, 1988), and anti-p24 (Chesebro et al., 1992) monoclonal 
antibodies (provided by the NIH AIDS Research and Reference Reagent Program). The 
relative level of each protein was determined by densitometry.
Indirect immunofluorescence
293T cells were transfected with NL4-3 or L95R proviral DNA. At 40 hpt, cells were fixed 
with 2% paraformaldehyde for surface gp120 staining or 2% formaldehyde + 0.05% Triton 
X-100 for intracellular staining of gp41 or gp120.
Flow cytometric analysis of gp120 cell surface expression
For efficient single-cycle HIV-1 replication assays (Bartz et al., 1996), pci-VSV G DNA 
was cotransfected with either NL4-3 or L95R proviral DNA in 293T cells using Effectene 
(Qiagen). Supernatants containing the VSV-G pseudotyped viruses were collected 48 hpt. 
SupT1 or CEMx174 cell lines were infected with equivalent RT units of VSV G-
pseudotyped NL4-3 and L95R viruses in the presence of 100 ng/ml AMD3100 {1,1′-[1,4-
phenylenebis(methylene)]-bis-1,4,8,11-tetra-azacyclotetradecane} (kindly provided by J. 
Moore, Aaron Diamond AIDS Research Center, New York) and 8 µg/ml polybrene. 
AMD3100 is a potent inhibitor of entry of CXCR4-tropic HIV-1 strains (Donzella et al., 
1998; Schols et al., 1997). Cells were then washed three times with PBS and maintained in 
medium containing 100 ng/ml AMD3100. Two days postinfection, cells were stained with 
an anti-gp120 antibody (0.5β), which recognizes the V3 loop region of NL4-3 gp120 
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(Burkly et al., 1995). Cells were then stained with goat anti-mouse IgG-FITC. Mouse IgG2b 
was used as an isotype control for background.
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Introduction of a mutation in the leucine zipper motif of the cytoplasmic domain of HIV-1 
gp41. (a) Functional domains of gp41. Fusion, fusion peptide; TM, transmembrane domain; 
LLP1 and LLP2, lentivirus lytic peptides 1 and 2. The numbers 1–151 indicate residue 
positions in the cytoplasmic domain of HIV-1 gp41 (gp41c). The LZ motif is shown in 
single-letter amino acid code, with the leucines comprising the LZ motif highlighted. The 
numbers 512–854 indicate residue positions in the HIV-1 gp160 env polypeptide. The Rev 
open reading frame remains unchanged. The numbers 8592–8619 indicate nucleotide 
positions in the NL4-3 genome. (b) L95R replication in vitro was cell type-dependent. 
SupT1, PBMC, or CEMx174 cells were infected with equivalent RT units of NL4-3 or 
L95R. Virus replication (RT activity) was monitored every 3 days for 15 or 24 days 
postinfection. The data are representative of three (PBMC) or four (T-cell lines) experiments 
with similar replication kinetics.
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L95R replication/pathogenesis was impaired in the SCID-hu Thy/Liv mouse. (a) HIV-1 
replication in SCID-hu Thy/Liv mice. SCID-hu Thy/Liv mice were infected with equivalent 
infectious units of NL4-3 or L95R. Virus replication (p24, pg/106 thymocytes) was 
monitored following infection. The data are representative of three independent experiments 
with 8–10 SCID-hu Thy/Liv mice for each virus. Error bars represent standard errors. (b) 
HIV-1 pathogenesis in SCID-hu Thy/Liv mice. Pathogenesis was determined by the 
percentage of total CD4+ (CD4+CD8+ and CD4+CD8−) thymocytes. Values for NL4-3- and 
L95R-infected Thy/Liv organs are presented relative to the mock-infected Thy/Liv organ 
(set as 100%). Error bars represent standard errors from 8–10 SCID-hu mice. (c) A 
representative FACS analysis of CD4/CD8 staining is shown to illustrate the relative 
thymocyte depletion by NL4-3 and L95R at 4 wpi in comparison to mock infection.
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NL4-3 and L95R env-pseudotyped virions showed similar reporter gene expression in the 
single-round replication assay. 293T cells were cotransfected with NL4-luc-R-E- and 
NL4-3- or L95R-env expressing plasmids. SupT1 or CEMx174 cells were infected with 
equivalent infectious units of viruses pseudotyped with NL4-3 or L95R env glycoproteins. 
Results are representative of three independent experiments with duplicate samples. Error 
bars represent standard errors.
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NL4-3 and L95R virions showed similar sensitivity to heat inactivation. Heat inactivation of 
NL4-3 and L95R virions produced from 293T cells was performed with equal number of 
IUs. Viral stocks incubated on ice (0°C) showed no reduction in IUs and were used as 
controls (100%). The remaining IU value after heat treatment was determined and is 
presented as the percentage IU. The experiment was performed three times in duplicate.
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L95R showed reduced cell surface expression of gp120. (a) Subcellular distribution of 
gp120 and gp41 in 293T cells transfected with NL4-3 or L95R provirus DNA was 
determined. Intracellular gp41 (top) or gp120 (middle) or surface gp120 (bottom) was 
visualized by standard fluorescence microscopy. Mock-transfected cells were used as 
negative controls. (b) FACS analysis of cell surface expression of gp120. CEMx174 or 
SupT1 cells were infected with VSV G-pseudotyped NL4-3 or L95R viruses. Cell surface 
gp120 levels were measured by FACS with an anti-gp120 antibody. The MFI is presented 
and standard errors (SE) are shown. MFI from each cell sample using an isotype control 
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antibody was the same as mock-infected cells (MFI is set to 0). Three independent 
experiments were performed with similar results.
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L95R produced more defective virions with reduced incorporation of env glycoproteins. (a) 
L95R produced more defective particles than NL4-3 in various cell lines. NL4-3 and L95R 
proviruses were transfected into 293T, CEMx174, and SupT1 T cells. Total virions were 
measured by RT activity in the supernatants and infectious virions (IU) were titered by 
MAGI assays. Data shown are the average of four independent experiments. Error bars 
represent standard errors. The IU/RT ratio of NL4-3 was set to 100%. A significant 
difference is observed between NL4-3 and L95R using Student’s T test (P < 0.01). (b) L95R 
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virions showed decreased env glycoproteins. Cell lysates and purified virions (pellet) were 
blotted with antibodies specific for gp41, gp120, or p24. The positions of gp160, gp120, 
gp41, and p24 are indicated. The experiment was repeated three times with similar results.
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TABLE 1
HIV-1 gp120/p24 and gp41/p24 Ratios
Proteinsa C-NL4-3b C-L95R V-NL4-3 V-L95R
gp120/p24 0.31 (0.13)c 0.2 (0.08) 0.34 (0.05) 0.07 (0.05)
gp41/p24 0.77 (0.25) 0.85 (0.31) 0.57 (0.12) 0.28 (0.11)
a
The level of each protein was calculated by densitometry.
b
Cell-associated (C−) or virion-associated (V−) proteins were determined by densitometry.
c
Standard deviations from multiple exposures of two experiments are shown in parentheses.
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